Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.3650
-0.1550 (-29.81%)
At close: Nov 16, 2026, 4:00 PM EST
0.3700
+0.0050 (1.37%)
Pre-market: Nov 17, 2026, 7:43 AM EST

Milestone Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
144.4773.0525.3113.767.64114.14
Short-Term Investments
0.8832.9144.3852.2456.95-
Cash & Short-Term Investments
145.35105.9669.76664.59114.14
Cash Growth
76.00%52.03%5.59%2.20%-43.42%-19.79%
Other Receivables
3.133.511.721.451.210.48
Receivables
7.063.511.721.451.210.48
Inventory
6.680.65----
Prepaid Expenses
2.511.811.843.186.014.3
Other Current Assets
--0.672.4--
Total Current Assets
161.6111.9273.9373.0371.8118.92
Property, Plant & Equipment
1.091.641.572.192.680.93
Total Assets
162.7113.5675.575.2374.48119.85

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.245.651.933.982.264.38
Accrued Expenses
14.56.345.622.73.382.17
Current Portion of Leases
0.690.650.570.550.50.22
Other Current Liabilities
0.041.35----
Total Current Liabilities
25.7813.988.137.236.146.78
Long-Term Debt
143.0757.1953.3549.77--
Long-Term Leases
0.010.540.871.4620.47
Other Long-Term Liabilities
0.050.08----
Total Liabilities
168.9171.7962.3558.468.147.25

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
384.99352.62288.05260.5273.9251.9
Additional Paid-In Capital
64.2364.139.5733.8324.4415.71
Retained Earnings
-511.08-430.6-367.55-326.03-266.34-207.95
Comprehensive Income & Other
55.6555.6553.0848.4634.3552.94
Total Common Equity
-6.2241.7713.1516.7766.35112.6
Shareholders' Equity
-6.2241.7713.1516.7766.35112.6
Total Liabilities & Equity
162.7113.5675.575.2374.48119.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
143.7758.3854.851.782.490.7
Net Cash (Debt)
1.5947.5814.914.2362.09113.44
Net Cash Growth
-93.74%219.39%4.71%-77.09%-45.26%-19.75%
Net Cash Per Share
0.010.570.240.331.462.71
Filing Date Shares Outstanding
124.516.4166.2643.0642.842.23
Total Common Shares Outstanding
124.5122.6566.2643.0642.842.23
Working Capital
135.8297.9465.865.8165.66112.15
Book Value Per Share
-0.050.340.200.391.552.67
Tangible Book Value
-6.2241.7713.1516.7766.35112.6
Tangible Book Value Per Share
-0.050.340.200.391.552.67
Machinery
-0.830.40.380.280.43
Leasehold Improvements
-0.090.090.090.10.03
SEC Filings: 10-K · 10-Q